Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 25, 2018
Patent Application Number
15126767
Date Filed
March 17, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to administration of various pharmaceutical formulations of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (cabozantinib) a c-Met inhibitor, and its metabolites, to achieve desirable pharmacokinetic and pharmacodynamic effects.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.